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Mouse Development and Cell Proliferation
in the Absence of D-Cyclins
activate, and provide substrate specificity for their cata-
lytic partners, CDKs. These cyclin-CDK complexes
phosphorylate critical cellular substrates, thereby allowing
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Among all cyclin classes, the family of D-type cyclinsRoderick T. Bronson,5 Koichi Akashi,2
and Piotr Sicinski1,* (cyclins D1, D2, and D3) stands out as a very unique
component of the cell cycle apparatus. Unlike other1Department of Cancer Biology
2 Department of Cancer Immunology and AIDS cyclins that fluctuate periodically during cell cycle pro-
gression, the levels of D-cyclins are controlled by theDana-Farber Cancer Institute and Department
of Pathology extracellular environment. Thus, D-cyclins are induced
by the mitogenic stimulation, and their levels declineHarvard Medical School
Boston, Massachusetts 02115 when the mitogens are withdrawn (Sherr and Roberts,
1999). Once induced, D-cyclins associate with partner3 Department of Pathology
Brigham and Women’s Hospital cyclin-dependent kinases CDK4 and CDK6. These
cyclin D-CDK complexes phosphorylate the retinoblas-Harvard Medical School
Boston, Massachusetts 02115 toma tumor suppressor protein, pRB, as well as pRB-
related proteins p107 and p130 (Sherr and Roberts,4 Department of Cardiovascular Medicine
University of Oxford 1999). The “preparatory” phosphorylation of pRB by
cyclin D-CDK4/6 is believed to represent a molecularOxford OX3 7BN
United Kingdom switch that allows further phosphorylation by cyclin
E-CDK2 and cyclin A-CDK2 complexes, leading to full5 Tufts University School of Veterinary Medicine
North Grafton, Massachusetts 01536 pRB inactivation (Harbour et al., 1999; Lundberg and
Weinberg, 1998). This, in turn, results in release or dere-
pression of the E2F transcription factors and drives cell
entry into the S phase (Dyson, 1998).Summary
Moreover, the induction of cyclin D-CDK complexes
causes redistribution of the cell cycle inhibitors p27Kip1D-type cyclins (cyclins D1, D2, and D3) are regarded
and p21Cip1 from cyclin E-CDK2 and cyclin A-CDK2 com-as essential links between cell environment and the
plexes (which are inhibited by p27Kip1 and p21Cip1) tocore cell cycle machinery. We tested the requirement
cyclin D-CDK complexes (which use these inhibitors asfor D-cyclins in mouse development and in prolifera-
assembly factors), thereby triggering kinase activitiestion by generating mice lacking all D-cyclins. We found
associated with cyclins E and A (Sherr and Roberts,that these cyclin D1/D2/D3/ mice develop until
1999). This represents yet another mechanism that sub-mid/late gestation and die due to heart abnormalities
jects the core cell cycle machinery to control by thecombined with a severe anemia. Our analyses revealed
extracellular mitogenic stimulation, via D-cyclins.that the D-cyclins are critically required for the expan-
Hence, according to our current understanding, thesion of hematopoietic stem cells. In contrast, cyclin
D-type cyclins appeared during the evolution to linkD-deficient fibroblasts proliferate nearly normally but
the extracellular mitogenic stimulation with the core cellshow increased requirement for mitogenic stimulation
cycle machinery. Importantly, most of the studies sug-in cell cycle re-entry. We found that the proliferation
gested that at least one D-cyclin is required to allowof cyclin D1/D2/D3/ cells is resistant to the inhi-
mammalian cell proliferation. The work described belowbition by p16INK4a, but it critically depends on CDK2.
challenges this notion and reveals that our understand-Lastly, we found that cells lacking D-cyclins display
ing of the core cell cycle machinery needs to be reeval-reduced susceptibility to the oncogenic transforma-
uated.tion. Our results reveal the presence of alternative
mechanisms that allow cell cycle progression in a
Resultscyclin D-independent fashion.
Embryonal Development in the AbsenceIntroduction
of D-Cyclins
In order to rigorously test the requirement for D-typeThe proliferation of mammalian cells is governed by
cyclins in development and in cell proliferation, we inter-cyclins and their associated cyclin-dependent kinases
crossed cyclin D1-, D2-, and D3-deficient animals in an(CDKs). Cyclins represent regulatory subunits that bind,
attempt to produce conceptuses lacking all D-cyclins.
Very unexpectedly, we observed that embryos lacking
*Correspondence: peter_sicinski@dfci.harvard.edu all three D-cyclins can develop normally as late as at
6 Present address: Department of Immunology, Center of Biostruc- embryonal day 13.5 (E13.5), i.e., at a stage when most
ture Research, The Medical University of Warsaw, 02-004 War-
of the tissues and organs are already formed (Figure 1A).saw, Poland.
At E15.5, a significant fraction of cyclin D1/D2/D3/7 Present address: Department of Embryology, Institute of Zoology,
University of Warsaw, 02-096 Warsaw, Poland. embryos remained viable, but the mutant embryos ap-
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Figure 1. Phenotype of Cyclin D1/D2/D3/ Mice
(A and B) Appearance of cyclin D1/D2/D3/ mice at embryonal day E13.5 (A) and E15.5 (B). Control littermates are shown for comparison.
(C) The ratios of the observed live cyclin D1/D2/D3/ embryos to the total number of embryos analyzed at different stages of embryonic
development. The numbers in parentheses refer to dead D1/D2/D3/ embryos.
(D) Bromodeoxyuridine incorporation in E13.5 embryos. Shown are sections through the developing retinas (R), neuroepithelium (N), vertebral
cartilages (V), and livers (L).
(E) Cardiac malformations in E15.5 cyclin D1/D2/D3/ embryos.
Upper panels: Histological transverse sections through the heart in the plane of the mitral valve (mv) and papillary muscle (pm). Cyclin
D1/D2/D3/ embryos show greatly reduced thickness of the compact zone and a large ventricular septal defect (VSD). Magnification, 25.
Lower panels: High-power view of wild-type and mutant hearts from the area indicated by the box in the upper panels. The compact (c) and
trabecular (t) zones of the myocardial wall are indicated. Magnification, 100. Axes: d, dorsal; v, ventral; r, right; l, left; ra, right atrium; la, left
atrium; rv, right ventricle; lv, left ventricle; ivs, interventricular septum; tv, tricuspid valve.
peared very pale (Figure 1B). No live cyclin D1/ tissues, we stained E13.5 embryonal sections for bromo-
deoxyuridine (BrdU) incorporation. As shown in the up-D2/D3/ embryos were observed after E16.5 (Fig-
ure 1C). per three panels of Figure 1D, the proliferation of most
tissues in cyclin D1/D2/D3/ embryos was veryIn order to gauge the proliferation of cyclin D-deficient
Cyclin D-Deficient Mice
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Figure 2. Hematopoietic Abnormalities in Cyclin D1/D2/D3/ Embryos
(A) Mean numbers of erythrocytes (RBC) per microliter of peripheral blood in E14.5 wild-type (wt, n  3) and cyclin D1/D2/D3/ (n  3)
mice. Error bars denote SD.
(B) Representative peripheral blood smears of E14.5 wild-type (wt) and cyclin D1/D2/D3/ mice stained with Giemsa.
(C) The mean number of myeloid colonies in methylcellulose cultures. 2  104 of wild-type (wt, n  3) or cyclin D1/D2/D3/ fetal liver
cells (n  3) were plated in duplicate. Colonies were counted after 12 to 14 days. BFU-E, burst-forming unit erythroid; CFU-G, CFU-M,
CFU-GM, and CFU-GEMM, colony-forming unit granulocyte, macrophage, granulocyte-macrophage, granulocyte-erythroid-megakaryocyte-
macrophage. Error bars denote SD.
(D) Upper row: Flow cytometric analyses of thymocytes isolated from intact Rag1/c/ mice (Rag), Rag1/c/ mice that received wild-
type fetal liver cells (wt), or Rag1/c/ mice that received cyclin D1/D2/D3/ fetal liver cells.
Second row: Similar analyses of B lymphocytes isolated from bone marrow. SSH-C, side scatter.
Third row: Similar analyses of natural killer cells isolated from spleens.
Fourth row: Analyses of Gr-1/Mac-1 cells in the bone marrow of intact Ly5.1 C57BL/6 mice (Ly5.1 C57BL/6), Ly5.1 C57BL/6 mice that
received wild-type fetal liver cells (wt), or Ly5.1 C57BL/6 mice that received cyclin D1/D2/D3/ fetal liver cells. Cells were stained with
antibodies against Ly5.2 and Gr-1/Mac-1. Donor-derived cells are Ly5.2 positive, recipients are Ly5.2 negative.
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Figure 3. Analyses of Hematopoietic Stem Cells and Lineage-Committed Progenitors
(A) Cells were isolated from fetal livers of E14.5 embryos and were stained for the presence of hematopoietic stem cells (HSC), common
lymphoid progenitors (CLP), common myeloid progenitors (CMP), granulocyte-macrophage progenitors (GMP), and megakaryocyte-erythroid
progenitors (MEP). The percentages of particular populations among all fetal liver cells are indicated.
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comparable to that seen in their wild-type counterparts. in methylcellulose in the presence of various cytokines,
and we tested the ability of hematopoietic progenitorsThese results indicate that normal cell proliferation can
to form colonies. Consistent with a severe anemia seenoccur in the absence of D-cyclins.
in cyclin D-deficient mice, we found that the number of
erythroid burst-forming units (BFU-E) was reduced 12.7-Phenotypes of Cyclin D-Deficient Mice
fold in mutant embryos (Figure 2C). Strikingly, we foundHistopathologic analyses of serially sectioned mutant
that cyclin D-deficient embryos were completely devoidembryos revealed normal morphogenesis in nearly all
of all other myeloid progenitors, such as CFU-G (col-major organs and in the extraembryonal tissues, includ-
ony-forming unit granulocytes), CFU-M (macrophages),ing placentas (data not shown). Hence, the overwhelm-
CFU-GM (granulocytes/macrophages), and CFU-GEMMing majority of compartments can develop normally, at
(mixed lineage including granulocytes, macrophages,least until this stage, in the absence of all D-cyclins.
erythrocytes, and megakaryocytes) (Figure 2C). TheseAn exception to this rule was provided by our observa-
results suggested a profound multilineage hematopoi-tions that mutant embryos displayed severely thinned
etic failure in mutant animals.walls of the heart ventricles, mainly affecting the com-
To probe this phenotype further, we performed bonepact zone (Figure 1E). In addition, cyclin D1/D2/
marrow reconstitution assays. In this procedure, fetalD3/ hearts showed a ventricular septal defect (Figure
liver cells are injected into tail veins of irradiated recipi-1E), an abnormality often seen in mutants with compact
ents, and the ability of hematopoietic stem cells to re-zone deficiency (Sucov, 1998). These lesions most likely
constitute various lymphoid and myeloid lineages isreflect proliferative failure of myocardial cells. The pro-
measured (Morrison et al., 1995). A successful long-termfound cardiac abnormalities in cyclin D1/D2/D3/
reconstitution indicates the presence of functional stemembryos resulted in a severe cardiac output failure, as
cells in donors’ fetal livers. Conversely, absence of theevidenced by generalized edema (data not shown), and
reconstitution suggests a stem cell failure in the donorlikely contributed to the lethality seen in cyclin D-defi-
animals (Park et al., 2003).cient embryos.
In the first set of experiments, we injected equal num-Pale appearance of cyclin D1/D2/D3/ embryos
bers of wild-type or cyclin D1/D2/D3/ fetal liversuggested that anemia might also contribute to the de-
cells into irradiated Rag1/c/ mice, and we mea-mise of mutant conceptuses. Indeed, we found that the
sured the contribution of the fetal cells to the lymphoidnumber of peripheral blood erythrocytes was reduced
lineages. Importantly, Rag1/c/ mice lack T and B
almost 8-fold in mutant embryos (Figure 2A). Impor-
lymphocytes as well as natural killer (NK) cells (Figure
tantly, some mature, enucleated erythrocytes were en-
2D), hence all the lymphoid cells in the reconstituted
countered in the mutant blood (Figure 2B), revealing that
mice are donor derived (Colucci et al., 2000). As ex-
limited definitive erythropoiesis does take place in cyclin
pected, injection of Rag1/c/ mice with wild-type
D-deficient animals, albeit at a very inefficient rate.
fetal liver cells led to the reconstitution of all lymphoid
We concluded that a severe anemia, together with a compartments (Figure 2D and data not shown). In con-
cardiac output failure, leads to lethality of mutant em- trast, mice reconstituted with cyclin D1/D2/D3/
bryos prior to day E17.5 of gestation. fetal liver cells presented empty lymphoid gates and
lacked any T cells, B cells, and NK cells (Figure 2D and
Hematopoietic Abnormalities in Cyclin data not shown). Hence, cyclin D-deficient fetal liver
D1/D2/D3/ Embryos cells are unable to contribute to the lymphoid com-
We next asked whether the hematopoietic abnormalities partment.
seen in cyclin D-deficient mice were restricted only to We next injected equal numbers of wild-type or cyclin
the erythroid lineage or, alternatively, other hematopoi- D1/D2/D3/ fetal liver cells into irradiated C57BL6
etic compartments were also affected. At embryonal Ly5.1 wild-type recipients. In this approach, the donor
day 14.5, fetal livers represent the major site of hemato- and recipient animals express different haplotypes of
poiesis, and they contain multipotent hematopoietic the Ly5 antigen on the surface of their hematopoietic
stem cells that are able to give rise to all myeloid and cells, thereby allowing unequivocal distinction of donor
lymphoid lineages (Morrison et al., 1995). We first iso- derived (Ly5.2 positive) from the host (Ly5.1 positive)
lated fetal liver cells from wild-type and cyclin D-defi- cells (Spangrude and Scollay, 1990). To assess ability
cient embryos and determined that the number of these of fetal liver cells to reconstitute various myeloid and
cells was reduced 4.7-fold in mutant animals (5.5  3  lymphoid lineages, we analyzed peripheral blood of the
106, n 9 in cyclin D1/D2/D3/, versus 25.6 2.7 recipients at 5, 10, and 15 weeks after the injections.
106, n  5 in wild-type). We next plated equal numbers We sacrificed the recipient animals at the end of a 15-
week observation period and analyzed their bone mar-of wild-type or cyclin D1/D2/D3/ fetal liver cells
(B) The bars represent total, absolute numbers of HSC, CLP, CMP, GMP, and MEP, calculated per liver, in wild-type and cyclin D1/D2/D3/
embryos. Error bars, SD.
(C) HSC or CMP were flow-sorted from the E14.5 fetal livers, as shown in (A), plated one-cell-per-well in 60 well plates and cultured in the
presence of cytokines. The percentage of cells that expanded to form colonies is shown. Colonies were individually picked and stained with
Giemsa. The type of the colonies is shown on the graph.
(D) HSC or CMP were plated at one-cell-per-well, as described in (C), and the number of cells per colony was enumerated.
(E) HSC were flow-sorted from the E14.5 fetal livers, as shown in (A), and their cell cycle status was determined by propidium iodide staining
followed by FACS analysis. Shown are percentages of cells in various stages of cell cycle progression.
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rows and spleens. As expected, wild-type fetal liver cells poietic colonies containing cells of multiple lineages.
In contrast, only 5% of cyclin D1/D2/D3/ HSCrobustly reconstituted the lymphoid and myeloid (Mac1
and Gr1) compartments of the recipient animals. In expanded to form small colonies (Figure 3C). Sequential
enumeration of the number of cells in individual coloniescontrast, no donor-derived lymphoid or myeloid cells
were present in the recipients of cyclin D1/ revealed that wild-type HSC underwent multiple cell divi-
sions and formed colonies containing more then 1000D2/D3/ liver cells (Figure 2D and data not shown).
Thus, cyclin D-deficient liver cells were unable to recon- cells on day 5. In contrast, the very few cyclin
D1/D2/D3/ stem cells that succeeded to expandstitute the hematopoietic lineages, suggesting an ab-
sence or greatly reduced levels of functional hematopoi- in vitro gave rise to colonies containing less than 10
cells (Figure 3D).etic stem cells in cyclin D1/D2/D3/ fetal livers.
Virtually identical results were obtained when the
expansion of single cell cultures of CMP was assayed.Analyses of Hematopoietic Stem Cells
Again, over 80% of wild-type CMP gave rise to myeloidDuring normal hematopoietic development, hematopoi-
colonies, containing up to 1000 cells per colony. In con-etic stem cells (HSC) give rise to common lymphoid
trast, no more than 5% of cyclin D1/D2/D3/ CMPprogenitors (CLP), which expand and produce pre-B and
expanded in vitro, producing colonies containing nopre-T cells (Figure 3B) (Kondo et al., 1997). Alternatively,
more than 15 cells (Figures 3C and 3D).HSC differentiate along the myeloid pathway, giving rise
Lastly, we wished to gauge the in vivo proliferativeto lineage-committed common myeloid progenitors
status of HSC in cyclin D-deficient embryos. We flow-(CMP), which in turn produce granulocyte-macrophage
sorted HSC from wild-type and cyclin D1/D2/D3/progenitors (GMP) and megakaryocyte-erythroid pro-
livers, and we determined their cell cycle distribution bygenitors (MEP) (Figure 3B) (Akashi et al., 2000; Traver
propidium iodide staining. Consistent with our in vitroet al., 2001).
observations, we found that the fraction of HSC in theOne possible explanation for the inability of cyclin
S and G2/M phases of the cell cycle was severely crip-D-deficient fetal liver cells to reconstitute hematopoietic
pled in mutant embryos (Figure 3E). Collectively, theselineages was the paucity of hematopoietic stem cells in
results indicate that cyclin D1/D2/D3/ livers con-cyclin D1/D2/D3/ animals. Alternatively, mutant
tain reduced numbers of HSC and of lineage-committedembryos might contain normal numbers of HSC, but the
hematopoietic progenitors, and the ability of these cellsexpansion and differentiation of these cells into various
to proliferate is profoundly impaired in the absence oflineages might be crippled in the absence of D-cyclins.
D-cyclins. This, together with relatively normal prolifera-To distinguish between these possibilities, we took ad-
tion rates and grossly normal development of other em-vantage of the fact that HSC, as well as lineage-commit-
bryonal tissues (except for the heart), reveals a uniqueted progenitors, can be prospectively isolated from the
requirement for the D-cyclins in the hematopoieticfetal livers based on their surface markers (Morrison et
lineage.al., 1995; Traver et al., 2001). We isolated cells from
wild-type and cyclin D1/D2/D3/ E14.5 livers and
determined the numbers of HSC and of various progeni- Molecular Analyses of Cyclin
D1/D2/D3/ Embryostors in these samples (Figure 3A). Our analyses revealed
that cyclin D1/D2/D3/ livers do contain HSC, but We next focused on nonhematopoietic tissues that de-
veloped normally in cyclin D1/D2/D3/ embryos.their absolute numbers (calculated per liver) were re-
duced approximately 5.7-fold in the mutant animals (Fig- In an attempt to understand the molecular basis of this
cyclin D-independent proliferation, we prepared lysatesures 3A and 3B). As a result, the numbers of lineage-
committed progenitors were profoundly affected in the from wild-type and cyclin D-deficient tissues, and we
determined the levels of cyclins, CDKs, and cell cycleabsence of D-cyclins. Thus, the total number of myeloid
progenitors, such as CMP and GMP, was reduced over inhibitors. As expected, cyclin D1/D2/D3/ em-
bryos lacked D-type cyclins (Figure 4A). Importantly,12-fold and 20-fold, respectively, while the number of
CLP was reduced 46-fold in the mutant animals (Figure the levels of other cell cycle regulators, as well as the
activities of cyclin E- and cyclin A-associated kinase3B). Interestingly, the numbers of MEP remained un-
changed in cyclin D-deficient embryos (Figure 3B), sug- activities were essentially unchanged in mutant em-
bryos (Figure 4A). Hence, at least at this level of resolu-gesting that the severe anemia in mutant mice is contrib-
uted by the impaired expansion of these progenitors. tion, no substantial alterations of the cell cycle machin-
ery took place in cyclin D1/D2/D3/ embryos. WeConsistent with this notion, we observed reduced prolif-
eration rates in cyclin D1/D2/D3/ fetal livers (Fig- noted that mutant embryos continued to express cyclin-
dependent kinases CDK4 and CDK6, which normallyure 1D), i.e., organs composed at this stage mostly of
the erythroid lineage. associate with the D-type cyclins (Sherr and Roberts,
1999). We speculated that in cyclin D1/D2/D3/We wished to directly test whether cyclin D1/
D2/D3/ HSC, while reduced in numbers, are able to cells, these CDKs might instead interact with other
cyclins. Such “partner switching” might explain rela-expand and to give rise to mature cells. To address
this issue, we purified HSC from wild-type and cyclin tively normal development of cyclin D-deficient em-
bryos.D1/D2/D3/ livers, plated single cells (one cell per
well), and cultured them in vitro in the presence of a To address this possibility, we determined the associ-
ation of CDK4 with various cyclins by immunoprecipita-cocktail of cytokines (Akashi et al., 2000). As expected,
nearly 90% of wild-type HSC cells gave rise to hemato- tion—Western blotting. As expected, CDK4 associated
Cyclin D-Deficient Mice
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Figure 4. Molecular Analyses of Cyclin D1/D2/D3/ Embryos
(A) Lysates prepared from E13.5 wild-type (wt) or cyclin D1/D2/D3/ embryos were immunoblotted and probed with the indicated anti-
bodies.
(B) Immunoprecipitation (IP)—Western blotting (WB) analyses of E13.5 embryos with the indicated antibodies.
exclusively with cyclins D1, D2, and D3 in the wild-type D2/D3/ embryos might occur in a CDK4- (and CDK6-)
independent fashion.embryos (Figure 4B). In cyclin D1/D2/D3/ em-
bryos, CDK4 did not partner with the D-type cyclins,
which were deleted, but it also did not associate with Resistance of Cyclin D1/D2/D3/ Cells
to p16INK4acyclins A, B, C, E, F, G, and H (Figure 4B). Importantly,
control experiments verified the association of these We reasoned that if the proliferation of cyclin
D1/D2/D3/ cells occurs in a truly CDK4- andcyclins with their normal catalytic partners in wild-type
and in mutant tissues (Figure 4B). CDK6-independent fashion, these mutant cells would
be resistant to p16INKa, an inhibitor of CDK4 and CDK6An important function of cyclin D-CDK4/6 complexes
is to sequester p27Kip1 (and p21Cip1) from cyclin E-CDK2 (Sherr and Roberts, 1999). To test this possibility, we
prepared fibroblasts (MEFs) from day E13.5 cyclinand cyclin A-CDK2 molecules, thereby triggering kinase
activities associated with cyclins E and A (Sherr and D1/D2/D3/ embryos. Mutant MEFs actively prolif-
erated in culture, although their S phase fraction wasRoberts, 1999). We asked whether CDK4 retained the
ability to sequester p27Kip1 in cyclin D1/D2/D3/ decreased, and the G1 fraction was increased as com-
pared with wild-type cells; the proliferation rate of cyclinembryos. While we detected abundant association of
p27Kip1 with CDK4 in wild-type samples, no p27Kip1-CDK4 D1/D2/D3/ cells in vitro was in the range of 60%–
80% of that seen in wild-type cells (Figures 5A andinteraction was detected in cyclin D1/D2/D3/ em-
bryo lysates (Figure 4B). Importantly, control immuno- 6C, right panel). We next infected wild-type and cyclin
D1/D2/D3/ MEFs with retroviruses encodingprecipitations revealed normal binding of p27Kip1 to
CDK2 in mutant samples (Figure 4B). These results sug- p16INKa, and we determined the impact of p16INK4a expres-
sion on cell proliferation. As expected, expression ofgested to us that the proliferation of cyclin D1/
Cell
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Figure 5. Proliferation of Cyclin D1/D2/D3/ Cells Is Resistant to p16INK4a but Sensitive to CDK2 siRNA
(A) Cell cycle distribution of asynchronously growing mouse embryo fibroblasts (MEFs) cultured in vitro. Cells were pulsed with bromodeoxyuri-
dine (BrdU) for 1 hr and then stained with anti-BrdU antibody and with propidium iodide (PI) followed by FACS analysis. The percentages of
cells in particular phases of cell cycle are shown.
(B) MEFs were infected with retroviruses encoding p16INK4a or p27Kip1, or with an empty vector, and the fraction of cells in the S phase was
scored by staining cells with PI followed by FACS. Results are shown as relative to S phase fraction of cells infected with an empty vector,
which was set as 100%. Error bars denote SD.
(C) MEFs were infected with retroviruses encoding two independent siRNAs against CDK2 (CDK2-A and CDK2-C), or with an empty vector,
and the effect on proliferation was gauged by determining [3H]thymidine uptake. Results are shown as relative to proliferation of cells infected
with an empty vector, which was set as 100%. Error bars denote SD.
(D) MEFs were infected with retroviruses encoding anti-CDK2 siRNAs, CDK2-A, or CDK2-C, or with the empty vector. Cells were serum starved
and then stimulated by serum. Re-entry of cells into the cell cycle was gauged by determining [3H]thymidine uptake.
(E) Western blot analyses of MEFs infected with retroviruses encoding indicated anti-CDK2 siRNA, or with control vector, probed with antibodies
against CDK2 or actin (loading control). Note that CDK2-C is more efficient than CDK2-A in bringing down CDK2 levels.
p16INK4a inhibited the proliferation of wild-type cells. In in CDK4- and CDK6-independent fashion caused us to
hypothesize that the proliferation of these cells mightcontrast, cyclin D1/D2/D3/ MEFs were resistant
to p16Ink4a inhibition (Figure 5B). Importantly, we verified be driven by CDK2-containing complexes. To address
this possibility, we infected wild-type and cyclin D1/that mutant cells remained susceptible to the inhibition
by p27Kip1, which targets cyclin E- and cyclin A-associ- D2/D3/ cells with retroviruses encoding two inde-
pendent siRNAs against CDK2, and we verified the suc-ated kinases (Figure 5B) (Sherr and Roberts, 1999).
These results suggest that the proliferation of cyclin cessful knockdown of CDK2 by Western blotting (Figure
5E). We also verified that the levels of other CDKs wereD1/D2/D3/ cells occurs in a CDK4- and CDK6-
independent fashion. unaffected by this procedure (data not shown). We found
that the knockdown of CDK2 had only small effect on
the proliferation of wild-type cells, consistent with recentProliferation of Cyclin D1/D2/D3/ Cells
Depends on CDK2 reports (Berthet et al., 2003; Ortega et al., 2003). In con-
trast, the proliferation of cyclin D1/D2/D3/ cellsTwo cyclin-CDK classes operate during the G1 phase
progression in mammalian cells: cyclin D-CDK4/6 and was strongly inhibited by CDK2 knockdown (Figure 5C).
Hence, the proliferation of cyclin D1/D2/D3/ cellscyclin E-CDK2 (Sherr and Roberts, 1999). Our demon-
stration that cyclin D1/D2/D3/ cells proliferated is critically dependent on CDK2.
Cyclin D-Deficient Mice
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Figure 6. Response of Cyclin D1/D2/D3/ Cells to Extracellular Mitogens
(A) Cells were grown in medium containing decreasing concentrations of serum, and the proliferation was gauged by measuring [3H]thymidine
incorporation. Proliferation of cells in 10% serum was set at 100%.
(B) Cells were grown in medium with 10% serum and then were rapidly changed to medium containing no serum. Proliferation was quantitated
by measuring [3H]thymidine incorporation. Proliferation of cells in 10% serum (time 0) was set as 100%.
(C) Cells were rendered quiescent by serum deprivation and then re-fed with medium containing indicated concentrations of serum. Entry of
cells into the S phase was scored by measuring [3H]thymidine incorporation. Righthand panel shows thymidine incorporation of the very same
cells prior to serum starvation (i.e., under conditions of continuous cell growth).
(D) Similar experiment as in (C), using medium with 10% of serum. The percentage of cells in the S phase was determined by staining cells
with the propidium iodide followed by FACS.
(E) Cells were rendered quiescent by serum deprivation and then stimulated to re-enter cell cycle by addition of medium with 10% of serum.
Cells were fixed after 24 hr and stained with an antibody against phospho-(Ser10) histone H3, a marker of mitotic cells, and co-stained with DAPI.
In an additional approach, we serum starved MEFs ous proliferation of cells, as well as their re-entry from
the G0 state is driven by CDK2-containing complexes.that expressed anti-CDK2 siRNA, and then forced them
to re-enter cell cycle by serum stimulation. In wild-type
cells, knockdown of CDK2 resulted in a slight delay of Response of Cyclin D1/D2/D3/ Cells
to the Extracellular Environmentthe S phase entry, consistent with the published results
(Berthet et al., 2003; Ortega et al., 2003). In contrast, S D-cyclins are assumed to represent critical cell cycle
“sensors” of the extracellular mitogenic environment.phase entry of cyclin D1/D2/D3/ cells was virtually
extinguished by both anti-CDK2 siRNAs (Figure 5D). We Hence, we tested the response of cells lacking D-cyclins
to changes in the external mitogenic stimulation. First,concluded that in the absence of D-cyclins, the continu-
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we cultured cells in medium containing decreasing con- Phosphorylation of the Retinoblastoma Protein
In addition to controlling the activity of cyclin E andcentrations of serum and gauged the rate of proliferation
cyclin A, cyclin D-CDK complexes were shown to phos-by measuring [3H]thymidine uptake. We found that cyclin
phorylate the retinoblastoma protein, pRB (Sherr andD1/D2/D3/ MEFs responded to reduced mito-
Roberts, 1999). For this reason, we gauged pRB phos-genic stimulation in a pattern that was essentially identi-
phorylation during cell cycle progression of cyclincal to that seen in wild-type cells (Figure 6A).
D1/D2/D3/ cells by Western blotting. As ex-We next rapidly switched cells grown in serum-rich
pected, the fully phosphorylated pRB species were(10%) medium to serum-free medium, and we followed
clearly detectable in wild-type cells at 15 hr poststimula-the response. Again, both wild-type and cyclin D1/
tion (Figure 7B). In contrast, the full phosphorylation ofD2/D3/ cells responded very similarly and exited
pRB was greatly diminished in cyclin D1/D2/D3/the cell cycle with virtually identical kinetics (Figure 6B).
cells (Figure 7B).Lastly, we analyzed the ability of cyclin D1/D2/
We next applied phosphospecific anti-pRB antibodiesD3/ cells to re-enter cell cycle from the quiescent
that allow detecting pRB species that are phosphory-state. We arrested cells in the G0 phase by serum depri-
lated at particular amino acid residues. We decided tovation and triggered cell cycle re-entry by the addition
focus on Ser249/Thr252, Ser807/Ser811, and Thr826of media containing different concentrations of serum.
since these pRB sites were shown to be phosphorylatedStimulation of mutant cells with medium containing 10%
exclusively by cyclin D-associated kinases (Zarkowskaof serum led to a robust S phase entry, with a similar
and Mittnacht, 1997). While all those cyclin D-specifickinetics as that seen in wild-type cells (Figures 6C and
sites were clearly phosphorylated in wild-type cells at6D). We verified that cyclin D1/D2/D3/ cells tra-
the G1/S boundary, their phosphorylation in cyclinversed the S and G2 phases, entered mitosis (as docu-
D1/D2/D3/ cells was very decreased (Figure 7C).mented by phospho-histone H3 staining, Figure 6E), and
According to our understanding of the cell cycle pro-eventually divided, resulting in an increase in cell num-
gression, the initial phosphorylation of the pRB by cyclinbers (data not shown). Hence, mutant MEFs can exit
D-CDK complexes is required to allow full phosphoryla-quiescence, re-enter the S, G2, and M phases, and com-
tion of the retinoblastoma protein by the cyclin E- andplete a productive cell division in the absence of any
cyclin A-associated kinases (Harbour et al., 1999; Lund-cyclin D activity.
berg and Weinberg, 1998). The absence of significantIn contrast, stimulation of cells with lower mitogen
cyclin D-dependent phosphorylation of pRB moleculesconcentrations (5% and 2.5% of serum) gave a very
in cyclin D1/D2/D3/ cells allowed us to test thisdifferent outcome. Whereas wild-type cells re-entered
model by probing Western blots with two independentthe cell cycle with efficiencies close to that observed
antibodies that recognize cyclin E- and A-specific pRBwith 10% of serum, the cell cycle re-entry was clearly
residue, Thr821. Our analyses revealed that this site wasreduced in cyclin D1/D2/D3/ cells (Figure 6C).
phosphorylated in cyclin D1/D2/D3/ cells (FigureHence, cyclin D-deficient cells show increased mito-
7C and data not shown). Hence, phosphorylation of pRBgenic requirement for cell cycle re-entry, as compared
on cyclin D-specific sites is not required for further phos-with wild-type cells.
phorylation, likely by cyclins E and A.
In addition to the retinoblastoma protein, the pRB-
Activation of Cyclins E and A related “pocket” proteins p107 and p130 also represent
in the Absence of D-Cyclins targets for cyclin D-CDK4/6 kinases (Sherr and Roberts,
Induction of D-cyclins in response to mitogenic stimula- 1999). For this reason, we analyzed the phosphorylation
tion is believed to drive cell cycle progression by titration of p107 during cell cycle re-entry of cyclin D1/
of p27Kip1 away from cyclin E-CDK and cyclin A-CDK D2/D3/ cells. As was the case with the retinoblas-
complexes, thereby triggering kinase activity associated toma protein, we found that the overall phosphorylation
with these holoenzymes (Sherr and Roberts, 1999). of p107 was clearly diminished in cells lacking D-type
Nearly normal cell cycle re-entry in cyclin D1/D2/ cyclins (Figure 7D).
D3/ cells stimulated with serum-rich medium prompted The phosphorylation of the pRB and pRB-related
us to analyze how these molecular events take place “pocket” proteins leads to the release or derepression
in the absence of D-cyclins. We serum starved cells, of the E2F transcription factors, which in turn control
stimulated to re-enter the cell cycle by addition of se- transcription of key target genes required for the S phase
rum-rich (10%) medium, and we collected cells at vari- entry (Dyson, 1998). Our observations that quiescent
ous time points during the G1 phase progression. We cyclin D1/D2/D3/ cells can re-enter the S phase,
found that in cyclin D1/D2/D3/ cells traversing undergo mitosis, and complete the entire cell division
the G1 phase, the levels of p27Kip1 were reduced, as cycle (Figures 6C, 6D, and 6E and data not shown) sug-
compared with the levels seen in wild-type cells (Figure gested to us that cyclin E- and cyclin A-driven phosphor-
7A). Reduction of p27Kip1 levels resulted in modest dere- ylation is sufficient to functionally inactivate the
pression of cyclin E-associated kinase activity at the “pocket” proteins and to release the E2Fs. To test this
early stages of cell cycle progression (Figure 7A). How- possibility, we measured the induction of known E2F
ever, the sharp, sudden induction of cyclin E- and cyclin target genes (cdc2, cyclin E, thymidylate synthase, p107)
A-associated kinase activities proceeded normally in the during cell cycle re-entry by Northern blotting. We found
absence of D-cyclins (Figure 7A). Hence, an additional that transcripts of these E2F targets were induced in
cyclin D-independent mechanism, which links extracel- cyclin D1/D2/D3/ cells (Figure 7E and data not
lular mitogenic stimulation with the sudden activation of shown); the maximal degree of induction was lower than
cyclin E-CDK2 and cyclin A-CDK2 at the G1/S boundary, that seen in wild-type cells, consistent with the smaller
fraction of cells re-entering the S phase in mutant sam-operates in mammalian cells.
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Figure 7. Molecular Analyses of G1 Phase
Progression in Cyclin D1/D2/D3/ Cells
(A) Upper panel: Cells were serum starved
and then stimulated to re-enter cell cycle by
addition of medium with 10% serum. Lysates
were prepared and immunoblotted with anti-
p27Kip1 antibody.
Middle and lower panels: Lysates were sub-
jected to immunoprecipitation with antibod-
ies against cyclin E or cyclin A, and kinase
activity towards histone H1 was determined.
Numbers above the lanes indicate hours after
serum stimulation.
(B) Similar experiment as in (A). The immu-
noblots were probed with an anti-pRB an-
tibody.
(C) Lysates prepared from cells collected at
2 or 18 hr after serum stimulation were used
for immunoblotting with anti-phosphospe-
cific antibodies that recognize pRB phos-
phorylated at particular amino acid residues.
(D) Cells were serum starved and restimu-
lated, as described in (A). Western blots were
probed with an anti-p107 antibody.
In (A)–(D), Righthand panels show similar
analyses of continuously growing cells.
(E) RNA was prepared from cells at indicated
time points after serum stimulation. Northern
blots were probed with cDNA probes against
indicated E2F targets or with ARPP P0 (load-
ing control).
ples. We concluded that cyclin E- and cyclin A-driven other than those associated with D-cyclins (possibly
cyclin E-CDK2 and/or cyclin A-CDK2) can bring aboutphosphorylation of the “pocket” proteins affords activa-
tion of the E2F targets. Together with our demonstration some phosphorylation of cyclin D-specific sites on pRB
and possibly on p107. It is important to note, however,that the proliferation and cell cycle re-entry of cyclin
D1/D2/D3/ cells is critically dependent on CDK2, that the levels of cyclin E- and cyclin A-associated ki-
nase activities are not elevated in continuously prolifer-we propose that cyclin E-CDK2 and cyclin A-CDK2 com-
plexes functionally inactivate “pocket” proteins in cyclin ating cyclin D1/D2/D3/ MEFs (Figure 7A, right
panel).D1/D2/D3/ cells.
We noted that in continuously proliferating cyclin
D1/D2/D3/MEFs, the phosphorylation of pRB and Reduced Susceptibility of Cyclin D1/D2/D3/
Cells to the Oncogenic Transformationp107 was not as strongly affected as in cells re-entering
the cell cycle (Figures 7B, 7C, and 7D, right panels). We D-type cyclins were postulated to represent the ultimate
recipients of several oncogenic pathways, including theconcluded that in continuously growing cells, kinases
Cell
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Figure 8. Reduced Sensitivity of Cyclin D1/D2/D3/ Cells to the Oncogenic Transformation
Appearance of crystal violet-stained plates and the mean number of foci or colonies seen in wild-type or cyclin D1/D2/D3/ MEFs infected
with retroviruses encoding indicated oncogenes. Error bars denote SD. In case of v-Ha-Ras plus E1A infection, low magnification of the crystal
violet-stained monolayers is shown.
ones triggered by the Ras and Myc oncogenes (Bouch- lapping fashion in all proliferating cell types. After the
discovery of the D-type cyclins (Matsushime et al., 1991;ard et al., 1999; Perez-Roger et al., 1999; Serrano et al.,
Motokura et al., 1991; Xiong et al., 1991), it was initially1995). This prompted us to test the susceptibility of cells
assumed that each of them is independently requiredlacking the D-cyclins to various oncogenic insults. To
to allow cell proliferation.this end, we infected monolayers of cyclin D1/D2/
In the past, we and others (Fantl et al., 1995) startedD3/ MEFs with retroviruses encoding Ras plus Myc,
to address the functions of the D-cyclins by creatingRas plus dominant-negative p53, or Ras plus E1A, and
mice lacking cyclins D1, D2, or D3. We found that allthe formation of transformed foci was scored in each
these strains were viable and displayed narrow, tissue-experiment. In addition, we infected cells with retrovi-
specific phenotypes. Thus, cyclin D1-deficient mice pre-ruses encoding only Myc, and the ability of this onco-
sented developmental neurological abnormalities andgene to cause immortalization was analyzed by enumer-
displayed hypoplastic retinas and hypoplastic mam-ation of the emerging colonies. We found that cyclin
mary glands (Fantl et al., 1995; Sicinski et al., 1995).D1/D2/D3/ cells displayed greatly reduced sus-
Cyclin D2-deficient females were sterile, owing to ovar-ceptibility to all these oncogenic insults (Figure 8).
ian granulosa cell defect, while cyclin D2/ males dis-Hence, the presence of D-cyclins is required to allow
played hypoplastic testes (Sicinski et al., 1996). In ad-full oncogenic transformation, at least by the oncogene
dition, cyclin D2-deficient animals showed cerebellarcombinations analyzed.
abnormalities (Huard et al., 1999), impaired proliferation
of B lymphocytes (Lam et al., 2000; Solvason et al.,
Discussion 2000), and hypoplasia of pancreatic  cells (J. Kushner,
personal communication). Lastly, cyclin D3-deficient
The three mammalian D-type cyclins show significant mice displayed defects in the development of T lympho-
cytes (Sicinska et al., 2003). Surprisingly, analyses ofamino acid similarity, and they are expressed in an over-
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mice lacking combinations of the two D-type cyclins et al., 2000). Hence, the cyclin D-independent mode of
proliferation also takes place in nonmammalian cells.failed to uncover any new phenotypes; instead these
The current notion that mammalian cells critically re-“single cyclin” mice displayed combinations of pheno-
quire D-cyclins for proliferation is largely based on thetypes associated with the deficiency of individual D-cyclins
observations that ectopic overexpression of the INK(Ciemerych et al., 2002). We interpreted these observa-
family of inhibitors (p16INK4a, p15INK4b, p18INK4c, and p19INK4d)tions as an indication that at least one D-type cyclin is
inhibits proliferation of in vitro cultured cells. However,sufficient to allow normal development, and that the
the major effect of INK inhibitors may be mediated by thenarrow, tissue-specific phenotypes of mice lacking indi-
liberation of cyclin D-CDK4/6 bound p27Kip1 and p21Cip1vidual D-type cyclins reflect the highly overlapping pat-
inhibitors. This mechanism of p16INK4a-mediated cell cy-tern of expression of the three D-type cyclins.
cle arrest does not take place in cyclin D1/D2/D3/We were puzzled, however, by the unexplained obser-
cells, as they do not have cyclin D-CDK4/6 complexes.vations that mice lacking catalytic effectors of the
We note that in the majority of cell types, p16INK4aD-cyclins, CDK4 and CDK6, display narrow tissue-spe-
inhibited but did not completely block cell cycle progres-cific abnormalities that affect the very similar compart-
sion. In contrast, expression of p16INKa in in vitro culturedments to those crippled in cyclin D-deficient animals.
hematopoietic stem cells was shown to completely shutThus, CDK4-deficient mice show developmental neuro-
off their proliferation (Park et al., 2003). Moreover, micelogical abnormalities that are similar to those observed
lacking Bmi-1, a repressor of p16INK4a, show elevatedin cyclin D1 null animals and present ovarian and testicu-
levels of p16INK4a and display a profound impairment oflar abnormalities and pancreatic  cell hypoplasia like
hematopoietic stem cell self-renewal (Park et al., 2003).cyclin D2/ mice (Rane et al., 1999; Tsutsui et al., 1999).
Hence, the proliferation of hematopoietic stem cells,CDK6-deficient mice, in turn, present erythroid and
and of few other “D-dependent” compartments, criti-lymphoid defects (Malumbres et al., 2004 [this issue of
cally requires D-type cyclins. We note here that theseCell]), resembling those observed in cyclin D3/ ani-
Bmi-1/ mice also display proliferative deficienciesmals. Moreover, mice lacking Bmi-1, a repressor of
within the neural stem cell compartment (Molofsky etcyclin D-CDK4/6 inhibitor, p16INK4a, display hypoplastic
al., 2003). It will be very interesting to determine whethercerebella, impaired development of the T lymphocytes,
these neural stem cells, and possibly other stem celland other hematopoietic abnormalities, again resem-
types, are also affected in cyclin D null animals.bling the phenotypes seen in cyclin D1-, D2-, or D3-
In contrast to hematopoietic stem cells, the prolifera-deficient mice (Jacobs et al., 1999; Park et al., 2003).
tion of fibroblasts proceeded relatively normally in theIn the work described here, we provide evidence that
absence of D-cyclins. Our demonstration that the prolif-the development of the majority of mouse tissues can
eration of these cells critically depends on CDK2 sug-occur in a cyclin D-independent fashion. We found that
gests that cyclin D-CDK4/6 and cyclin E-CDK2 com-the function of D-cyclins is critically required for de-
plexes may perform overlapping functions in “cyclinvelopment only in few selected compartments. Impor-
D-independent” cell types. The exact molecular func-tantly, the very same compartments require CDK4 and
tions of these complexes do not need to be identical.CDK6, as evidenced by very similar phenotypes of cy-
For instance, the retinoblastoma protein contains 16clin D1/D2/D3/ mice (this study) and CDK4/
consensus CDK phosphorylation sites and the majorityCDK6/ animals (Malumbres et al., 2004). Collectively,
of them can be phosphorylated by cyclin D-, E-, andthese observations provide genetic evidence that the
A-associated kinases (Zarkowska and Mittnacht, 1997).major function of the D-cyclins in development is to
A small subset of pRB sites can be phosphorylated onlyactivate CDK4 and CDK6, and they unexpectedly reveal
by cyclin D-CDK complexes (Zarkowska and Mittnacht,that the majority of mammalian cell types can develop
1997), and these sites remain hypophosphorylated inand proliferate in the absence of cyclin D-CDK4/6 activ-
cyclin D1/D2/D3/ cells. However, cyclin E- and
ity. One of the major challenges in the field will be to
A-driven phosphorylation of pRB appears to suffice for
identify the differences in the cell cycle machinery of
the functional inactivation of pRB and allows normal cell
“cyclin D-dependent” versus “cyclin D-independent” cycle progression.
cell types. While the activity of cyclin E and A may suffice to
The notion that normal proliferation can occur in the allow cell proliferation, an important question is how
absence of cyclin D-CDK4 activity was first proposed these cyclins are activated in response to the environ-
by the findings of Cheng et al. (1999), who reported mental cues in the absence of the D-type cyclins. Our
that fibroblasts lacking p27Kip1 and p21Cip1 can proliferate results clearly indicate the presence of an alternative,
normally in the absence of any detectable cyclin D-CDK cyclin D-independent mechanism that couples the acti-
complexes. These findings raised a possibility of cyclin vation of cyclins E and A to the extracellular environment
D-independent proliferation in mammalian cells. (see Figure 7A). While the molecular basis of this mecha-
In Caenorhabditis elegans, the RNAi-mediated inacti- nism is currently unknown, cyclin D1/D2/D3/ cells
vation of cyd-1 or cdk-4 genes, which encode homologs offer us a tool to address this issue.
of mammalian D-cyclins and CDK4/6, respectively, does Consistent with the growth-promoting functions for
not interfere with normal embryonal development and D-cyclins, amplification of the cyclin D genes and over-
only affects proliferation of postembryonic blast cells expression of cyclin D proteins was reported in several
(Park and Krause, 1999). Likewise, deletion of the Dro- human cancers. The most frequent of these is the
sophila melanogaster cdk4 gene, a homolog of mamma- involvement of cyclin D1 overexpression in the majority
lian CDK4 and CDK6, affects cell growth rather than cell of human breast cancers (Weinstat-Saslow et al., 1995).
Our demonstration that D-cyclins are dispensable forproliferation and results in viable, smaller flies (Meyer
Cell
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ral vector. Cells were infected, selected in puromycin for 3 days, andproliferation of a great number of cell types, but not for
plated for the experiments. Proliferation was scored by measuringoncogenic transformation by Ras and Myc, may offer a
[3H]thymidine uptake or by staining cells with propidium iodide.window of opportunity for targeting D cyclins in hu-
man malignancies. Western and Northern Blotting
Western blots, immunoprecipitations (IP), or kinase assays were
Experimental Procedures done as described (Ciemerych et al., 2002) using antibodies against
cyclins D2, D3, E, F, H, CDK2, CDK4, CDK6, p21, p27, all from Santa
Histopathologic Analyses Cruz, cyclin A (Sigma), cyclins B, C, D1, CDK1 (NeoMarkers), cyclin
Organs or embryos were fixed in Bouin’s fixative (Sigma) and pro- G1 (from Dr. P. Hinds), pRB (BD Biosciences), pRB pSer249/Thr252,
cessed for histology. Bromodeoxyuridine staining was performed pRB pThr826 (EMD Biosciences), pRB pSer807/Ser811 (Cell Signal-
as described (Ciemerych et al., 2002). Peripheral blood was obtained ing), pRB pThr821 (Abcam). For IP-kinase assays, we used antibod-
from carotid arteries of viable E14.5 embryos. Blood smears were ies against cyclins E or A (Santa Cruz). For Northern blotting, 20 g
prepared using the wedge technique, followed by air drying and of total RNA was resolved on MOPS gels as described (Sicinska et
Wright-Giemsa staining. al., 2003) and probed with 32P-labeled cDNA probes.
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